VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
Clinical trial NCT07028086 · RECRUITING
Trial details
- NCT number
- NCT07028086
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.